Healthcare Sector Stocks
The Healthcare sector has a total of 1062 stocks, with a combined market cap of $8.39 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.67.
Market Cap
8.39T
Revenue
4.52T
Profits
201.27B
PE Ratio
41.67
Profit Margin
4.45%
Dividend Yield
0.42%
1062 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 804.32B | -2.56% | 1,934,808 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 571.73B | -1.14% | 2,775,225 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 367.90B | -1.07% | 2,474,805 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 313.96B | -1.98% | 1,062,281 | 58.74B |
| 5 | NVS | Novartis AG | 294.01B | -1.15% | 699,771 | 56.67B |
| 6 | MRK | Merck & Co., Inc. | 291.57B | -1.59% | 3,835,327 | 65.01B |
| 7 | UNH | UnitedHealth Group Incorporated | 284.09B | -0.38% | 3,006,004 | 447.57B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 196.68B | 0.38% | 883,647 | 44.56B |
| 9 | AMGN | Amgen Inc. | 187.03B | -1.25% | 628,596 | 36.75B |
| 10 | ABT | Abbott Laboratories | 177.37B | 0.78% | 5,177,533 | 44.33B |
| 11 | NVO | Novo Nordisk A/S | 176.49B | 2.42% | 12,037,930 | 48.59B |
| 12 | GILD | Gilead Sciences, Inc. | 173.15B | -0.68% | 1,477,515 | 29.44B |
| 13 | ISRG | Intuitive Surgical, Inc. | 165.58B | -0.22% | 840,906 | 10.06B |
| 14 | PFE | Pfizer Inc. | 154.92B | 0.46% | 15,298,801 | 62.58B |
| 15 | DHR | Danaher Corporation | 140.42B | -0.10% | 1,242,716 | 24.57B |
| 16 | SYK | Stryker Corporation | 131.02B | -1.09% | 923,786 | 25.12B |
| 17 | GSK | GSK plc | 118.71B | -2.43% | 2,211,018 | 43.97B |
| 18 | BMY | Bristol-Myers Squibb Company | 117.60B | -0.83% | 3,585,828 | 48.19B |
| 19 | SNY | Sanofi | 115.44B | 0.70% | 2,001,157 | 54.85B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 112.04B | -0.86% | 624,337 | 12.00B |
| 21 | MDT | Medtronic plc | 111.12B | -1.78% | 3,701,223 | 35.48B |
| 22 | HCA | HCA Healthcare, Inc. | 108.75B | -2.45% | 442,616 | 75.60B |
| 23 | MCK | McKesson Corporation | 105.56B | -0.12% | 203,533 | 397.96B |
| 24 | CVS | CVS Health Corporation | 96.31B | -3.18% | 4,100,275 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 95.62B | 0.81% | 5,601,177 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.72B | -1.05% | 234,276 | 14.34B |
| 27 | CI | The Cigna Group | 70.91B | -1.34% | 597,549 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 68.07B | -1.10% | 513,886 | 199.13B |
| 29 | MDLN | Medline Inc. | 62.68B | 0.08% | 1,785,908 | 28.43B |
| 30 | COR | Cencora, Inc. | 61.78B | -0.72% | 530,129 | 325.78B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 56.24B | -0.03% | 1,731,071 | 28.48B |
| 32 | ARGX | argenx SE | 51.73B | 1.68% | 159,054 | 4.24B |
| 33 | ZTS | Zoetis Inc. | 50.89B | -0.07% | 998,711 | 9.47B |
| 34 | CAH | Cardinal Health, Inc. | 49.84B | -1.46% | 472,486 | 244.67B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 46.17B | -0.48% | 171,181 | 4.30B |
| 36 | EW | Edwards Lifesciences Corporation | 44.87B | -0.47% | 2,162,496 | 6.07B |
| 37 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.50B | -1.14% | 338,515 | 3.71B |
| 38 | BDX | Becton, Dickinson and Company | 44.08B | -0.60% | 1,045,821 | 21.92B |
| 39 | HLN | Haleon plc | 43.21B | -0.36% | 14,767,476 | 14.85B |
| 40 | ALC | Alcon Inc. | 39.36B | 0.89% | 966,102 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 36.51B | -1.31% | 1,646,676 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 35.01B | 1.83% | 98,574 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 34.10B | 0.22% | 910,675 | 7.07B |
| 44 | GEHC | GE HealthCare Technologies Inc. | 33.72B | -1.04% | 1,061,800 | 20.63B |
| 45 | RMD | ResMed Inc. | 33.06B | -1.20% | 509,041 | 5.40B |
| 46 | WAT | Waters Corporation | 32.37B | -0.37% | 259,813 | 3.17B |
| 47 | INSM | Insmed Incorporated | 31.94B | -3.53% | 1,195,429 | 606.42M |
| 48 | IQV | IQVIA Holdings Inc. | 29.93B | 1.71% | 455,173 | 16.31B |
| 49 | NTRA | Natera, Inc. | 29.90B | -1.71% | 702,827 | 2.31B |
| 50 | RVMD | Revolution Medicines, Inc. | 29.66B | 1.82% | 7,655,486 | - |
| 51 | RPRX | Royalty Pharma plc | 28.02B | -0.49% | 762,952 | 2.38B |
| 52 | PHG | Koninklijke Philips N.V. | 27.79B | -0.38% | 302,350 | 20.94B |
| 53 | VEEV | Veeva Systems Inc. | 27.12B | 4.36% | 1,611,986 | 3.20B |
| 54 | MTD | Mettler-Toledo International Inc. | 26.62B | -2.01% | 77,225 | 4.03B |
| 55 | BIIB | Biogen Inc. | 26.33B | 0.25% | 372,295 | 9.89B |
| 56 | UTHR | United Therapeutics Corporation | 25.53B | 0.68% | 203,187 | 3.18B |
| 57 | BNTX | BioNTech SE | 25.17B | 1.15% | 205,275 | 3.37B |
| 58 | DXCM | DexCom, Inc. | 23.77B | -1.89% | 1,965,678 | 4.66B |
| 59 | HUM | Humana Inc. | 23.70B | 0.62% | 441,878 | 129.66B |
| 60 | LH | Labcorp Holdings Inc. | 22.03B | -0.30% | 189,664 | 13.95B |
| 61 | STE | STERIS plc | 21.76B | -1.29% | 326,459 | 5.83B |
| 62 | MRNA | Moderna, Inc. | 21.45B | 2.35% | 2,979,561 | 1.94B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.31B | -0.82% | 242,327 | 11.04B |
| 64 | ROIV | Roivant Sciences Ltd. | 20.84B | - | 1,586,542 | 13.31M |
| 65 | ILMN | Illumina, Inc. | 20.06B | 1.31% | 606,932 | 4.34B |
| 66 | INCY | Incyte Corporation | 19.44B | - | 495,977 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 19.22B | -0.38% | 348,001 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 18.36B | -1.75% | 1,051,849 | 8.23B |
| 69 | CNC | Centene Corporation | 18.25B | -0.38% | 1,108,225 | 176.15B |
| 70 | GMAB | Genmab A/S | 17.84B | 0.45% | 556,171 | 3.72B |
| 71 | THC | Tenet Healthcare Corporation | 16.71B | -2.24% | 655,332 | 21.31B |
| 72 | SMMT | Summit Therapeutics Inc. | 16.39B | 1.39% | 2,425,005 | - |
| 73 | VTRS | Viatris Inc. | 16.15B | -0.29% | 2,553,875 | 14.30B |
| 74 | ASND | Ascendis Pharma A/S | 15.00B | -2.85% | 302,729 | 845.52M |
| 75 | BBIO | BridgeBio Pharma, Inc. | 14.92B | -1.24% | 637,364 | 502.08M |
| 76 | MEDP | Medpace Holdings, Inc. | 14.87B | 0.16% | 336,812 | 2.53B |
| 77 | SNN | Smith & Nephew plc | 14.64B | -0.49% | 575,031 | 6.16B |
| 78 | RGC | Regencell Bioscience Holdings Limited | 14.52B | -2.51% | 40,979 | - |
| 79 | PODD | Insulet Corporation | 13.99B | 0.25% | 332,186 | 2.71B |
| 80 | COO | The Cooper Companies, Inc. | 13.64B | -2.36% | 727,086 | 4.15B |
| 81 | ALGN | Align Technology, Inc. | 13.32B | 0.71% | 221,708 | 4.03B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.18B | 0.41% | 309,283 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 13.08B | 0.11% | 99,073 | 1.40B |
| 84 | GMED | Globus Medical, Inc. | 12.81B | -0.22% | 426,076 | 2.94B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.63B | -0.43% | 398,400 | 943.71M |
| 86 | FMS | Fresenius Medical Care AG | 12.62B | -1.68% | 288,561 | 23.05B |
| 87 | JAZZ | Jazz Pharmaceuticals plc | 12.31B | -0.57% | 317,068 | 4.27B |
| 88 | SOLV | Solventum Corporation | 11.93B | -0.30% | 385,860 | 8.33B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.80B | -1.99% | 132,659 | 958.40M |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.66B | -3.17% | 1,336,630 | 4.72B |
| 91 | ENSG | The Ensign Group, Inc. | 11.50B | -0.80% | 81,933 | 5.06B |
| 92 | EXEL | Exelixis, Inc. | 11.48B | -3.64% | 808,156 | 2.32B |
| 93 | GH | Guardant Health, Inc. | 11.27B | -0.56% | 584,437 | 982.02M |
| 94 | UHS | Universal Health Services, Inc. | 11.00B | -0.92% | 185,360 | 17.36B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 10.88B | -1.79% | 1,172,837 | 3.85B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.67B | 0.02% | 350,567 | 3.22B |
| 97 | EHC | Encompass Health Corporation | 10.40B | -1.93% | 321,974 | 5.94B |
| 98 | RVTY | Revvity, Inc. | 10.39B | -0.59% | 151,699 | 2.86B |
| 99 | ABVX | ABIVAX Société Anonyme | 9.88B | -3.79% | 671,858 | 5.37M |
| 100 | TEM | Tempus AI, Inc. | 9.84B | 10.84% | 8,681,468 | 1.27B |
| 101 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.75B | 4.41% | 1,041,839 | 1.09B |
| 102 | DVA | DaVita Inc. | 9.61B | -3.69% | 330,582 | 13.64B |
| 103 | PRAX | Praxis Precision Medicines, Inc. | 9.43B | -1.48% | 372,221 | 7.46M |
| 104 | AXSM | Axsome Therapeutics, Inc. | 9.38B | -0.46% | 261,830 | 638.50M |
| 105 | MASI | Masimo Corporation | 9.31B | - | 254,749 | 1.53B |
| 106 | BTSG | BrightSpring Health Services, Inc. | 9.27B | -1.30% | 702,451 | 12.91B |
| 107 | TECH | Bio-Techne Corporation | 9.19B | 0.15% | 625,157 | 1.22B |
| 108 | BAX | Baxter International Inc. | 9.07B | -0.11% | 1,499,638 | 11.24B |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.96B | 1.52% | 251,592 | 4.02B |
| 110 | HSIC | Henry Schein, Inc. | 8.85B | -0.05% | 307,455 | 13.18B |
| 111 | PCVX | Vaxcyte, Inc. | 8.75B | -3.08% | 442,818 | - |
| 112 | ICLR | ICON Public Limited Company | 8.71B | 0.95% | 368,746 | 8.10B |
| 113 | QGEN | Qiagen N.V. | 8.61B | -0.29% | 803,310 | 2.09B |
| 114 | ATR | AptarGroup, Inc. | 8.28B | -0.87% | 92,603 | 3.78B |
| 115 | NUVL | Nuvalent, Inc. | 8.20B | -0.70% | 318,148 | - |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.03B | 0.76% | 284,146 | 1.40B |
| 117 | CYTK | Cytokinetics, Incorporated | 8.03B | -1.69% | 501,502 | 88.04M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.99B | 1.31% | 35,354 | 2.58B |
| 119 | KRYS | Krystal Biotech, Inc. | 7.87B | -0.97% | 113,179 | 389.13M |
| 120 | IBRX | ImmunityBio, Inc. | 7.75B | -1.25% | 5,957,576 | 113.29M |
| 121 | MOH | Molina Healthcare, Inc. | 7.63B | -0.72% | 1,048,473 | 43.56B |
| 122 | RGEN | Repligen Corporation | 7.45B | 0.76% | 356,050 | 738.26M |
| 123 | KYMR | Kymera Therapeutics, Inc. | 7.22B | -1.56% | 165,791 | 39.21M |
| 124 | HQY | HealthEquity, Inc. | 7.04B | 2.40% | 396,111 | 1.31B |
| 125 | GRFS | Grifols, S.A. | 6.95B | 2.65% | 211,853 | 8.83B |
| 126 | GKOS | Glaukos Corporation | 6.94B | -0.75% | 160,284 | 507.44M |
| 127 | ACLX | Arcellx, Inc. | 6.75B | 0.17% | 415,286 | 22.29M |
| 128 | BLTE | Belite Bio, Inc | 6.64B | -1.79% | 52,272 | - |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.61B | -1.07% | 329,401 | 46.02M |
| 130 | APGE | Apogee Therapeutics, Inc. | 6.55B | 0.18% | 514,450 | - |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.05% | 2,826,980 | 15.00M |
| 132 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.09% | 2,656,354 | - |
| 133 | PTCT | PTC Therapeutics, Inc. | 6.05B | 0.19% | 167,697 | 1.73B |
| 134 | BRKR | Bruker Corporation | 6.05B | -0.43% | 593,420 | 3.44B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.97B | 0.11% | 152,437 | 189.76M |
| 136 | CELC | Celcuity Inc. | 5.94B | 1.69% | 231,018 | - |
| 137 | BLCO | Bausch + Lomb Corporation | 5.93B | 0.18% | 79,872 | 5.10B |
| 138 | COGT | Cogent Biosciences, Inc. | 5.85B | -0.41% | 720,713 | - |
| 139 | CAI | Caris Life Sciences, Inc. | 5.82B | 2.03% | 695,312 | 812.03M |
| 140 | MIRM | Mirum Pharmaceuticals, Inc. | 5.82B | -0.46% | 236,432 | 521.31M |
| 141 | ERAS | Erasca, Inc. | 5.72B | 3.03% | 3,922,739 | - |
| 142 | AVTR | Avantor, Inc. | 5.68B | 2.44% | 3,166,045 | 6.55B |
| 143 | SRRK | Scholar Rock Holding Corporation | 5.67B | -0.34% | 498,853 | - |
| 144 | CGON | CG Oncology, Inc. | 5.66B | -0.30% | 497,258 | 4.04M |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 5.62B | -0.69% | 415,480 | 7.50M |
| 146 | TFX | Teleflex Incorporated | 5.55B | 0.30% | 276,720 | 1.99B |
| 147 | ALKS | Alkermes plc | 5.52B | -2.01% | 533,411 | 1.48B |
| 148 | IMVT | Immunovant, Inc. | 5.49B | 1.62% | 532,282 | - |
| 149 | LNTH | Lantheus Holdings, Inc. | 5.41B | 0.56% | 230,694 | 1.54B |
| 150 | CRSP | CRISPR Therapeutics AG | 5.40B | -1.08% | 1,287,538 | 3.51M |
| 151 | PACS | PACS Group, Inc. | 5.39B | 3.50% | 398,589 | 5.29B |
| 152 | APLS | Apellis Pharmaceuticals, Inc. | 5.22B | 0.05% | 1,564,365 | 1.00B |
| 153 | SYRE | Spyre Therapeutics, Inc. | 5.22B | 3.73% | 2,188,497 | - |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 5.20B | 0.59% | 389,649 | 2.04M |
| 155 | TGTX | TG Therapeutics, Inc. | 5.08B | -0.43% | 604,021 | 616.29M |
| 156 | CHE | Chemed Corporation | 5.03B | -0.43% | 82,374 | 2.53B |
| 157 | HIMS | Hims & Hers Health, Inc. | 4.93B | 1.26% | 10,876,868 | 2.35B |
| 158 | CORT | Corcept Therapeutics Incorporated | 4.68B | 0.66% | 359,583 | 761.41M |
| 159 | WAY | Waystar Holding Corp. | 4.66B | 8.49% | 1,967,955 | 1.10B |
| 160 | OSCR | Oscar Health, Inc. | 4.57B | 0.56% | 3,785,817 | 11.70B |
| 161 | SHC | Sotera Health Company | 4.56B | 0.38% | 1,367,626 | 1.16B |
| 162 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.03% | 2,323,934 | 634.21M |
| 163 | RDNT | RadNet, Inc. | 4.49B | 0.23% | 161,858 | 2.04B |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 4.44B | -4.07% | 196,577 | 268.09M |
| 165 | NVST | Envista Holdings Corporation | 4.42B | -0.99% | 764,745 | 2.72B |
| 166 | OPCH | Option Care Health, Inc. | 4.41B | 0.57% | 1,148,957 | 5.65B |
| 167 | DOCS | Doximity, Inc. | 4.36B | 6.16% | 1,837,423 | 637.78M |
| 168 | MMED | MiniMed Group, Inc. | 4.36B | 2.04% | 469,064 | 2.89B |
| 169 | ALHC | Alignment Healthcare, Inc. | 4.26B | -2.11% | 495,177 | 3.95B |
| 170 | MMSI | Merit Medical Systems, Inc. | 4.16B | -0.65% | 100,251 | 1.52B |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.14B | -0.53% | 301,353 | 7.70M |
| 172 | AMRX | Amneal Pharmaceuticals, Inc. | 4.13B | -1.30% | 373,268 | 3.02B |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.10B | -0.45% | 1,069,766 | - |
| 174 | IRTC | iRhythm Holdings, Inc. | 4.04B | 1.38% | 94,274 | 747.14M |
| 175 | STVN | Stevanato Group S.p.A. | 4.03B | -0.17% | 124,323 | 1.39B |
| 176 | TMDX | TransMedics Group, Inc. | 3.99B | 0.65% | 152,356 | 605.49M |
| 177 | NAMS | NewAmsterdam Pharma Company N.V. | 3.87B | -2.15% | 400,416 | 22.50M |
| 178 | TVTX | Travere Therapeutics, Inc. | 3.84B | -1.21% | 1,992,228 | 490.73M |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | -0.45% | 512,954 | 1.07B |
| 180 | GPCR | Structure Therapeutics Inc. | 3.71B | -1.66% | 633,268 | - |
| 181 | LEGN | Legend Biotech Corporation | 3.64B | 5.30% | 1,297,919 | 1.03B |
| 182 | BLLN | BillionToOne, Inc. | 3.63B | -4.58% | 310,367 | 305.11M |
| 183 | TLX | Telix Pharmaceuticals Limited | 3.58B | -1.50% | 204,700 | 803.79M |
| 184 | LIVN | LivaNova PLC | 3.56B | 0.28% | 574,358 | 1.39B |
| 185 | LQDA | Liquidia Corporation | 3.54B | 3.80% | 388,690 | 158.32M |
| 186 | TNGX | Tango Therapeutics, Inc. | 3.52B | 2.62% | 2,954,734 | 62.38M |
| 187 | EWTX | Edgewise Therapeutics, Inc. | 3.52B | -0.97% | 577,655 | - |
| 188 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.50B | -2.51% | 347,785 | 677.56M |
| 189 | TWST | Twist Bioscience Corporation | 3.49B | -0.91% | 576,779 | 391.56M |
| 190 | DNLI | Denali Therapeutics Inc. | 3.34B | 4.61% | 650,795 | - |
| 191 | BKD | Brookdale Senior Living Inc. | 3.31B | -0.11% | 1,324,707 | 3.05B |
| 192 | ORKA | Oruka Therapeutics, Inc. | 3.28B | -1.28% | 801,878 | - |
| 193 | DYN | Dyne Therapeutics, Inc. | 3.26B | -0.45% | 1,603,001 | - |
| 194 | TXG | 10x Genomics, Inc. | 3.24B | 2.18% | 969,474 | 642.82M |
| 195 | HNGE | Hinge Health, Inc. | 3.17B | 3.76% | 318,172 | 587.86M |
| 196 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.15B | -1.37% | 416,442 | 588.99M |
| 197 | ICUI | ICU Medical, Inc. | 3.11B | -2.80% | 92,986 | 2.23B |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 3.08B | -1.86% | 69,313 | 451.36M |
| 199 | VERA | Vera Therapeutics, Inc. | 3.06B | -3.88% | 537,473 | - |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | -2.11% | 240,668 | 376.07M |
| 201 | BEAM | Beam Therapeutics Inc. | 3.01B | -0.13% | 1,119,995 | 139.74M |
| 202 | ALMS | Alumis Inc. | 2.99B | 2.69% | 709,330 | 24.05M |
| 203 | ITGR | Integer Holdings Corporation | 2.97B | -1.71% | 136,469 | 1.85B |
| 204 | PRVA | Privia Health Group, Inc. | 2.94B | 1.19% | 293,429 | 2.12B |
| 205 | WRBY | Warby Parker Inc. | 2.90B | 2.25% | 864,049 | 871.91M |
| 206 | RCUS | Arcus Biosciences, Inc. | 2.88B | - | 678,448 | 247.00M |
| 207 | HAE | Haemonetics Corporation | 2.88B | 2.50% | 207,602 | 1.32B |
| 208 | SUPN | Supernus Pharmaceuticals, Inc. | 2.87B | -0.66% | 135,490 | 718.95M |
| 209 | CON | Concentra Group Holdings Parent, Inc. | 2.86B | -2.07% | 201,891 | 2.16B |
| 210 | MANE | Veradermics, Incorporated | 2.85B | 1.69% | 338,046 | - |
| 211 | IDYA | IDEAYA Biosciences, Inc. | 2.79B | -1.92% | 1,183,674 | 218.71M |
| 212 | VCYT | Veracyte, Inc. | 2.73B | 0.23% | 259,281 | 517.15M |
| 213 | SLNO | Soleno Therapeutics, Inc. | 2.72B | -0.03% | 3,684,349 | 190.41M |
| 214 | PBH | Prestige Consumer Healthcare Inc. | 2.70B | 0.53% | 87,701 | 1.10B |
| 215 | RLAY | Relay Therapeutics, Inc. | 2.69B | 2.00% | 1,884,521 | 15.36M |
| 216 | IRON | Disc Medicine, Inc. | 2.68B | -0.34% | 138,569 | - |
| 217 | CLDX | Celldex Therapeutics, Inc. | 2.65B | 1.40% | 449,720 | 1.55M |
| 218 | KOD | Kodiak Sciences Inc. | 2.65B | -4.81% | 385,005 | - |
| 219 | ELVN | Enliven Therapeutics, Inc. | 2.63B | -1.96% | 443,178 | - |
| 220 | LMAT | LeMaitre Vascular, Inc. | 2.61B | -2.37% | 53,341 | 249.60M |
| 221 | IMNM | Immunome, Inc. | 2.61B | 0.61% | 296,577 | 6.94M |
| 222 | HCM | HUTCHMED (China) Limited | 2.59B | -0.07% | 37,946 | 548.51M |
| 223 | ZLAB | Zai Lab Limited | 2.59B | 4.60% | 781,593 | 460.16M |
| 224 | ADMA | ADMA Biologics, Inc. | 2.55B | 1.91% | 2,031,365 | 510.17M |
| 225 | LFST | LifeStance Health Group, Inc. | 2.54B | -0.08% | 260,607 | 1.42B |
| 226 | HTFL | HeartFlow, Inc. | 2.50B | 0.17% | 550,321 | 176.03M |
| 227 | AAPG | Ascentage Pharma Group International | 2.50B | 5.10% | 1,231 | 82.08M |
| 228 | RARE | Ultragenyx Pharmaceutical Inc. | 2.49B | 3.09% | 920,453 | 673.00M |
| 229 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | 10.03% | 2,265,684 | - |
| 230 | NHC | National HealthCare Corporation | 2.47B | -3.09% | 57,089 | 1.52B |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.42B | -1.17% | 637,845 | 3.31B |
| 232 | XRAY | DENTSPLY SIRONA Inc. | 2.41B | -1.15% | 1,156,629 | 3.68B |
| 233 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.39B | -1.55% | 2,944,578 | 874.84M |
| 234 | NKTR | Nektar Therapeutics | 2.36B | 1.37% | 309,010 | 55.23M |
| 235 | GRDN | Guardian Pharmacy Services, Inc. | 2.33B | -2.70% | 129,761 | 1.45B |
| 236 | OGN | Organon & Co. | 2.32B | 2.53% | 4,075,582 | 6.22B |
| 237 | SRPT | Sarepta Therapeutics, Inc. | 2.29B | -1.58% | 1,053,158 | 2.20B |
| 238 | PAHC | Phibro Animal Health Corporation | 2.26B | -5.44% | 195,050 | 1.46B |
| 239 | ADPT | Adaptive Biotechnologies Corporation | 2.25B | 0.69% | 345,957 | 276.98M |
| 240 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | - | 387,312 | 158.18M |
| 241 | DFTX | Definium Therapeutics, Inc. | 2.16B | -1.12% | 558,864 | - |
| 242 | BHC | Bausch Health Companies Inc. | 2.13B | 0.62% | 312,171 | 10.27B |
| 243 | SNDX | Syndax Pharmaceuticals, Inc. | 2.13B | -1.06% | 378,443 | 172.35M |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | -0.31% | 424,854 | 283.06M |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.10B | -1.13% | 126,016 | 184.42M |
| 246 | NEOG | Neogen Corporation | 2.06B | -1.56% | 555,548 | 870.56M |
| 247 | GRAL | GRAIL, Inc. | 2.04B | -1.41% | 202,082 | 147.17M |
| 248 | SEM | Select Medical Holdings Corporation | 2.03B | - | 2,854,105 | 5.45B |
| 249 | ZYME | Zymeworks Inc. | 2.02B | 1.63% | 252,768 | 105.97M |
| 250 | CAPR | Capricor Therapeutics, Inc. | 2.02B | 1.15% | 394,867 | 11.13M |
| 251 | MESO | Mesoblast Limited | 2.00B | 7.67% | 160,312 | 65.38M |
| 252 | WGS | GeneDx Holdings Corp. | 2.00B | 1.99% | 345,986 | 427.54M |
| 253 | SION | Sionna Therapeutics, Inc. | 1.99B | 2.33% | 497,627 | - |
| 254 | ANAB | AnaptysBio, Inc. | 1.98B | -1.95% | 109,428 | 234.60M |
| 255 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | 1.26% | 207,813 | 54.03M |
| 256 | RXRX | Recursion Pharmaceuticals, Inc. | 1.94B | 3.81% | 7,707,115 | 74.68M |
| 257 | ESTA | Establishment Labs Holdings Inc. | 1.94B | -0.87% | 154,895 | 211.08M |
| 258 | OCUL | Ocular Therapeutix, Inc. | 1.93B | 1.20% | 1,321,303 | 51.95M |
| 259 | GLPG | Galapagos NV | 1.92B | 0.55% | 86,696 | 1.31B |
| 260 | TYRA | Tyra Biosciences, Inc. | 1.89B | -0.74% | 598,821 | - |
| 261 | AHG | Akso Health Group | 1.88B | -6.78% | 149,495 | 14.84M |
| 262 | PHVS | Pharvaris N.V. | 1.87B | -0.10% | 36,854 | - |
| 263 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.87B | -0.24% | 350,951 | -665.00K |
| 264 | AORT | Artivion, Inc. | 1.82B | -0.95% | 89,281 | 441.33M |
| 265 | PVLA | Palvella Therapeutics, Inc. | 1.81B | -2.36% | 82,663 | - |
| 266 | AXGN | Axogen, Inc. | 1.80B | 0.90% | 221,982 | 225.21M |
| 267 | TRVI | Trevi Therapeutics, Inc. | 1.79B | -0.43% | 380,264 | - |
| 268 | MD | Pediatrix Medical Group, Inc. | 1.79B | -2.21% | 227,849 | 1.91B |
| 269 | VCEL | Vericel Corporation | 1.79B | -0.26% | 162,179 | 276.26M |
| 270 | INVA | Innoviva, Inc. | 1.77B | -1.16% | 197,034 | 411.33M |
| 271 | RAPP | Rapport Therapeutics, Inc. | 1.76B | 1.72% | 116,226 | - |
| 272 | ANIP | ANI Pharmaceuticals, Inc. | 1.75B | -2.02% | 98,901 | 883.37M |
| 273 | NTLA | Intellia Therapeutics, Inc. | 1.74B | -0.34% | 1,600,767 | 67.67M |
| 274 | ATEC | Alphatec Holdings, Inc. | 1.73B | -0.52% | 922,926 | 764.16M |
| 275 | AHCO | AdaptHealth Corp. | 1.72B | -1.17% | 401,993 | 3.24B |
| 276 | TSHA | Taysha Gene Therapies, Inc. | 1.71B | 26.11% | 3,478,800 | 9.77M |
| 277 | NRIX | Nurix Therapeutics, Inc. | 1.70B | 0.80% | 865,216 | 71.78M |
| 278 | HRMY | Harmony Biosciences Holdings, Inc. | 1.70B | 0.20% | 291,234 | 868.45M |
| 279 | OMCL | Omnicell, Inc. | 1.69B | 2.09% | 183,391 | 1.18B |
| 280 | ADUS | Addus HomeCare Corporation | 1.69B | -0.30% | 60,821 | 1.42B |
| 281 | SGRY | Surgery Partners, Inc. | 1.68B | -0.04% | 299,758 | 3.31B |
| 282 | INSP | Inspire Medical Systems, Inc. | 1.65B | 1.02% | 308,808 | 911.98M |
| 283 | NUVB | Nuvation Bio Inc. | 1.65B | -0.62% | 945,631 | 62.90M |
| 284 | OCS | Oculis Holding AG | 1.63B | - | 57,095 | 1.51M |
| 285 | SNDA | Sonida Senior Living, Inc. | 1.62B | 1.13% | 272,067 | 336.39M |
| 286 | VIR | Vir Biotechnology, Inc. | 1.62B | 0.90% | 1,410,524 | 68.56M |
| 287 | NBTX | Nanobiotix S.A. | 1.61B | 4.27% | 52,663 | 38.27M |
| 288 | DMRA | Damora Therapeutics, Inc. | 1.59B | -1.42% | 190,078 | - |
| 289 | GENB | Generate Biomedicines, Inc. | 1.59B | -3.49% | 118,255 | 31.89M |
| 290 | IMCR | Immunocore Holdings plc | 1.58B | -1.55% | 54,576 | 400.02M |
| 291 | PRGO | Perrigo Company plc | 1.58B | - | 739,173 | 4.25B |
| 292 | BCAX | Bicara Therapeutics Inc. | 1.56B | 3.52% | 343,958 | - |
| 293 | BHVN | Biohaven Ltd. | 1.55B | -1.05% | 830,291 | - |
| 294 | MBX | MBX Biosciences, Inc. | 1.54B | -1.34% | 150,810 | - |
| 295 | ARDX | Ardelyx, Inc. | 1.53B | -1.34% | 2,373,527 | 407.32M |
| 296 | VRDN | Viridian Therapeutics, Inc. | 1.52B | -1.91% | 446,161 | 70.85M |
| 297 | IOVA | Iovance Biotherapeutics, Inc. | 1.52B | 1.24% | 6,806,180 | 263.50M |
| 298 | UFPT | UFP Technologies, Inc. | 1.50B | -0.87% | 116,608 | 602.80M |
| 299 | SVRA | Savara Inc. | 1.49B | -3.13% | 487,993 | - |
| 300 | ATRC | AtriCure, Inc. | 1.49B | -0.07% | 241,750 | 534.53M |
| 301 | IMTX | Immatics N.V. | 1.46B | -0.27% | 178,382 | 56.67M |
| 302 | ENOV | Enovis Corporation | 1.46B | 1.00% | 133,700 | 2.25B |
| 303 | AVAH | Aveanna Healthcare Holdings Inc. | 1.45B | 0.75% | 399,732 | 2.43B |
| 304 | TNDM | Tandem Diabetes Care, Inc. | 1.44B | -0.71% | 656,777 | 1.01B |
| 305 | PRCT | PROCEPT BioRobotics Corporation | 1.43B | 3.13% | 535,872 | 308.05M |
| 306 | ASTH | Astrana Health, Inc. | 1.43B | -0.79% | 150,189 | 3.18B |
| 307 | GLUE | Monte Rosa Therapeutics, Inc. | 1.43B | 1.89% | 236,782 | 123.67M |
| 308 | HROW | Harrow, Inc. | 1.43B | 1.08% | 172,636 | 272.30M |
| 309 | ATAI | AtaiBeckley Inc. | 1.43B | 1.56% | 1,619,876 | 4.09M |
| 310 | OLMA | Olema Pharmaceuticals, Inc. | 1.42B | -0.18% | 304,158 | - |
| 311 | WVE | Wave Life Sciences Ltd. | 1.41B | 1.49% | 2,075,925 | 42.73M |
| 312 | NVAX | Novavax, Inc. | 1.41B | 3.22% | 1,539,940 | 1.12B |
| 313 | PGEN | Precigen, Inc. | 1.39B | -1.01% | 1,215,617 | 9.68M |
| 314 | NVCR | NovoCure Limited | 1.38B | 7.70% | 933,343 | 655.35M |
| 315 | PGNY | Progyny, Inc. | 1.35B | 0.58% | 698,290 | 1.29B |
| 316 | HCSG | Healthcare Services Group, Inc. | 1.35B | 0.68% | 147,280 | 1.84B |
| 317 | MAZE | Maze Therapeutics, Inc. | 1.34B | -2.35% | 405,402 | 2.50M |
| 318 | ARDT | Ardent Health, Inc. | 1.34B | -0.96% | 104,662 | 6.32B |
| 319 | PLSE | Pulse Biosciences, Inc. | 1.33B | -2.83% | 112,778 | 350.00K |
| 320 | MLTX | MoonLake Immunotherapeutics | 1.30B | -3.73% | 457,048 | - |
| 321 | PHAR | Pharming Group N.V. | 1.27B | 1.53% | 2,930 | 376.13M |
| 322 | DBVT | DBV Technologies S.A. | 1.27B | -2.45% | 157,302 | 5.64M |
| 323 | AVBP | ArriVent BioPharma, Inc. | 1.25B | 2.17% | 158,072 | - |
| 324 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | -3.34% | 537,369 | - |
| 325 | ZBIO | Zenas BioPharma, Inc. | 1.23B | -3.37% | 469,233 | 10.00M |
| 326 | BFLY | Butterfly Network, Inc. | 1.22B | 8.33% | 3,219,262 | 97.61M |
| 327 | STAA | STAAR Surgical Company | 1.21B | 0.29% | 386,011 | 239.44M |
| 328 | NNNN | Anbio Biotechnology | 1.21B | -4.37% | 27,034 | 8.65M |
| 329 | INBX | Inhibrx Biosciences, Inc. | 1.20B | -1.29% | 179,366 | 1.30M |
| 330 | IRMD | IRADIMED CORPORATION | 1.20B | 0.25% | 28,513 | 83.81M |
| 331 | EYPT | EyePoint, Inc. | 1.20B | -0.07% | 289,653 | 31.37M |
| 332 | MPLT | MapLight Therapeutics, Inc. | 1.19B | 0.33% | 87,628 | - |
| 333 | QDEL | QuidelOrtho Corporation | 1.19B | 1.21% | 809,063 | 2.73B |
| 334 | CNMD | CONMED Corporation | 1.18B | -1.23% | 115,739 | 1.37B |
| 335 | KMTS | Kestra Medical Technologies, Ltd. | 1.16B | 0.91% | 96,870 | 83.72M |
| 336 | ABCL | AbCellera Biologics Inc. | 1.16B | 1.60% | 2,317,797 | 75.13M |
| 337 | AZTA | Azenta, Inc. | 1.15B | 3.34% | 290,050 | 595.03M |
| 338 | AVNS | Avanos Medical, Inc. | 1.14B | -0.12% | 2,659,940 | 701.20M |
| 339 | COLL | Collegium Pharmaceutical, Inc. | 1.14B | -1.09% | 203,105 | 780.57M |
| 340 | ALVO | Alvotech | 1.14B | 3.12% | 103,814 | 588.90M |
| 341 | USPH | U.S. Physical Therapy, Inc. | 1.13B | -2.74% | 96,911 | 773.34M |
| 342 | EVO | Evotec SE | 1.13B | 2.72% | 86,239 | 925.65M |
| 343 | NEO | NeoGenomics, Inc. | 1.13B | 3.95% | 626,982 | 727.33M |
| 344 | CLOV | Clover Health Investments, Corp. | 1.10B | 2.45% | 2,732,215 | 1.92B |
| 345 | INNV | InnovAge Holding Corp. | 1.09B | -1.47% | 101,841 | 915.37M |
| 346 | GERN | Geron Corporation | 1.09B | -4.24% | 15,208,302 | 183.88M |
| 347 | SEPN | Septerna, Inc. | 1.08B | -0.08% | 575,103 | 45.95M |
| 348 | QURE | uniQure N.V. | 1.05B | -1.29% | 674,555 | 16.10M |
| 349 | XERS | Xeris Biopharma Holdings, Inc. | 1.05B | 0.58% | 496,260 | 291.85M |
| 350 | PNTG | The Pennant Group, Inc. | 1.05B | -1.96% | 52,408 | 947.71M |
| 351 | IVA | Inventiva S.A. | 1.04B | 2.54% | 238,696 | 9.31M |
| 352 | KALV | KalVista Pharmaceuticals, Inc. | 1.04B | -0.10% | 229,090 | 73.62M |
| 353 | GHRS | GH Research PLC | 1.03B | -0.54% | 32,997 | - |
| 354 | URGN | UroGen Pharma Ltd. | 1.03B | -0.45% | 563,521 | 109.79M |
| 355 | PHAT | Phathom Pharmaceuticals, Inc. | 1.02B | 1.26% | 245,379 | 175.11M |
| 356 | CMPX | Compass Therapeutics, Inc. | 1.01B | 3.49% | 963,897 | 850.00K |
| 357 | BLFS | BioLife Solutions, Inc. | 1.01B | 3.45% | 106,311 | 96.21M |
| 358 | ORIC | ORIC Pharmaceuticals, Inc. | 1.01B | -4.18% | 905,328 | - |
| 359 | ANNX | Annexon, Inc. | 1.01B | 8.28% | 2,631,234 | - |
| 360 | AKTS | Aktis Oncology, Inc. | 995.52M | 0.95% | 52,032 | 6.50M |
| 361 | TDOC | Teladoc Health, Inc. | 995.08M | 5.25% | 3,650,374 | 2.53B |
| 362 | EVMN | Evommune, Inc. | 981.86M | 2.37% | 101,135 | 13.00M |
| 363 | CRON | Cronos Group Inc. | 977.92M | 4.67% | 1,021,950 | 146.59M |
| 364 | SSII | SS Innovations International, Inc. | 975.71M | -0.20% | 24,325 | 42.48M |
| 365 | CTMX | CytomX Therapeutics, Inc. | 972.80M | -0.88% | 2,512,551 | 76.20M |
| 366 | AMPH | Amphastar Pharmaceuticals, Inc. | 971.83M | 0.19% | 129,989 | 719.89M |
| 367 | JBIO | Jade Biosciences, Inc. | 950.32M | -0.87% | 140,740 | - |
| 368 | PCRX | Pacira BioSciences, Inc. | 947.87M | -1.43% | 137,436 | 726.41M |
| 369 | FTRE | Fortrea Holdings Inc. | 946.69M | 5.58% | 495,935 | 2.72B |
| 370 | CERT | Certara, Inc. | 934.52M | 4.73% | 984,358 | 418.84M |
| 371 | MGTX | MeiraGTx Holdings plc | 917.08M | -0.27% | 328,715 | 81.39M |
| 372 | SDGR | Schrödinger, Inc. | 915.43M | 4.11% | 930,596 | 255.87M |
| 373 | SANA | Sana Biotechnology, Inc. | 915.35M | -1.44% | 3,169,371 | - |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 914.97M | -4.70% | 561,515 | 1.02B |
| 375 | CDNA | CareDx, Inc. | 908.07M | 0.57% | 209,653 | 379.81M |
| 376 | XNCR | Xencor, Inc. | 904.27M | -1.44% | 319,022 | 125.58M |
| 377 | JANX | Janux Therapeutics, Inc. | 899.09M | -3.02% | 516,106 | 10.00M |
| 378 | INMD | InMode Ltd. | 899.06M | 0.35% | 335,233 | 370.50M |
| 379 | CGEM | Cullinan Therapeutics, Inc. | 893.37M | 2.86% | 448,580 | - |
| 380 | OPK | OPKO Health, Inc. | 891.90M | 0.43% | 558,161 | 606.88M |
| 381 | OMER | Omeros Corporation | 888.43M | 4.22% | 754,757 | - |
| 382 | ABUS | Arbutus Biopharma Corporation | 882.58M | 3.79% | 2,345,065 | 14.08M |
| 383 | DRUG | Bright Minds Biosciences Inc. | 874.86M | -0.55% | 64,718 | - |
| 384 | SLS | SELLAS Life Sciences Group, Inc. | 872.77M | - | 1,640,637 | - |
| 385 | IART | Integra LifeSciences Holdings Corporation | 863.54M | 0.18% | 439,793 | 1.64B |
| 386 | TALK | Talkspace, Inc. | 862.95M | -0.10% | 1,532,790 | 228.87M |
| 387 | MRVI | Maravai LifeSciences Holdings, Inc. | 862.46M | 2.29% | 666,444 | 185.74M |
| 388 | BVS | Bioventus Inc. | 853.17M | 3.53% | 463,813 | 568.09M |
| 389 | VOR | Vor Biopharma Inc. | 850.71M | -1.07% | 530,335 | - |
| 390 | TBPH | Theravance Biopharma, Inc. | 850.15M | -0.54% | 124,598 | 107.46M |
| 391 | MNKD | MannKind Corporation | 838.38M | -0.91% | 1,866,757 | 348.97M |
| 392 | SGP | SpyGlass Pharma, Inc. | 829.65M | 1.22% | 14,431 | - |
| 393 | SPRY | ARS Pharmaceuticals, Inc. | 809.27M | 0.12% | 708,996 | 84.28M |
| 394 | SLDB | Solid Biosciences Inc. | 807.30M | -0.30% | 479,574 | - |
| 395 | ANRO | Alto Neuroscience, Inc. | 806.30M | -2.25% | 166,724 | - |
| 396 | KURA | Kura Oncology, Inc. | 794.08M | -1.64% | 395,015 | 67.48M |
| 397 | TLRY | Tilray Brands, Inc. | 791.51M | -1.45% | 1,781,558 | 858.28M |
| 398 | FBRX | Forte Biosciences, Inc. | 789.91M | -0.46% | 95,038 | - |
| 399 | GDRX | GoodRx Holdings, Inc. | 789.63M | 3.36% | 1,229,239 | 796.85M |
| 400 | DSGN | Design Therapeutics, Inc. | 781.39M | 0.24% | 236,377 | - |
| 401 | CBLL | CeriBell, Inc. | 769.39M | 4.55% | 164,543 | 89.06M |
| 402 | LXRX | Lexicon Pharmaceuticals, Inc. | 768.98M | 3.71% | 1,129,735 | 49.80M |
| 403 | OMDA | Omada Health, Inc. | 768.98M | 4.74% | 333,077 | 260.21M |
| 404 | CMPS | COMPASS Pathways plc | 754.20M | 1.74% | 1,422,852 | - |
| 405 | CSTL | Castle Biosciences, Inc. | 747.10M | 1.19% | 83,900 | 344.23M |
| 406 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 746.31M | 1.58% | 258,202 | - |
| 407 | AMN | AMN Healthcare Services, Inc. | 745.69M | 2.72% | 169,926 | 2.73B |
| 408 | NUTX | Nutex Health Inc. | 744.92M | -0.87% | 206,190 | 875.26M |
| 409 | BIOA | BioAge Labs, Inc. | 742.03M | 0.91% | 187,027 | 9.00M |
| 410 | ETON | Eton Pharmaceuticals, Inc. | 738.05M | -0.26% | 195,436 | 79.95M |
| 411 | RLMD | Relmada Therapeutics, Inc. | 734.22M | -2.64% | 476,680 | - |
| 412 | GYRE | Gyre Therapeutics, Inc. | 727.32M | 1.59% | 24,831 | 116.59M |
| 413 | TENX | Tenax Therapeutics, Inc. | 709.99M | -4.50% | 339,385 | - |
| 414 | IRWD | Ironwood Pharmaceuticals, Inc. | 709.30M | 7.67% | 1,536,031 | 296.15M |
| 415 | LBRX | LB Pharmaceuticals Inc | 707.62M | 5.27% | 236,051 | - |
| 416 | EHAB | Enhabit, Inc. | 695.67M | -1.61% | 991,764 | 1.06B |
| 417 | DRTS | Alpha Tau Medical Ltd. | 694.40M | 0.77% | 164,071 | - |
| 418 | ARVN | Arvinas, Inc. | 693.98M | -1.36% | 352,026 | 262.60M |
| 419 | PSNL | Personalis, Inc. | 693.49M | -0.82% | 1,035,372 | 69.65M |
| 420 | PRME | Prime Medicine, Inc. | 657.85M | 0.41% | 914,808 | 4.63M |
| 421 | CBIO | Crescent Biopharma, Inc. | 655.31M | 1.08% | 86,892 | 10.84M |
| 422 | BWAY | BrainsWay Ltd. | 650.12M | 4.61% | 193,133 | 52.23M |
| 423 | SIBN | SI-BONE, Inc. | 640.40M | 0.49% | 230,253 | 200.93M |
| 424 | OCGN | Ocugen, Inc. | 633.56M | 4.17% | 3,148,394 | 4.41M |
| 425 | HSTM | HealthStream, Inc. | 609.73M | 2.11% | 60,697 | 304.06M |
| 426 | PROK | ProKidney Corp. | 597.79M | 3.66% | 1,493,681 | 893.00K |
| 427 | CTKB | Cytek Biosciences, Inc. | 595.83M | 0.32% | 101,582 | 201.49M |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 591.25M | 2.86% | 363,002 | 106.47M |
| 429 | EIKN | Eikon Therapeutics, Inc. | 590.11M | 2.73% | 134,529 | - |
| 430 | AVR | Anteris Technologies Global Corp. | 587.88M | -0.56% | 241,904 | 1.91M |
| 431 | RIGL | Rigel Pharmaceuticals, Inc. | 584.67M | 0.83% | 140,652 | 294.28M |
| 432 | PRTA | Prothena Corporation plc | 583.55M | 2.17% | 134,445 | 9.68M |
| 433 | BBNX | Beta Bionics, Inc. | 580.64M | 10.33% | 959,789 | 100.25M |
| 434 | MDXG | MiMedx Group, Inc. | 576.44M | -1.02% | 396,717 | 418.63M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 576.04M | 1.04% | 85,350 | 329.52M |
| 436 | CRMD | CorMedix Inc. | 574.70M | -0.41% | 480,821 | 311.71M |
| 437 | EMBC | Embecta Corp. | 571.47M | 2.01% | 206,043 | 1.08B |
| 438 | KYTX | Kyverna Therapeutics, Inc. | 561.63M | -0.75% | 310,700 | - |
| 439 | LYEL | Lyell Immunopharma, Inc. | 553.35M | 1.50% | 45,637 | 36.00K |
| 440 | VSTM | Verastem, Inc. | 552.53M | 2.44% | 1,253,589 | 30.91M |
| 441 | ACRS | Aclaris Therapeutics, Inc. | 551.12M | 1.15% | 441,674 | 7.83M |
| 442 | PHR | Phreesia, Inc. | 548.08M | 4.88% | 732,422 | 480.59M |
| 443 | TECX | Tectonic Therapeutic, Inc. | 543.40M | -3.37% | 87,188 | - |
| 444 | UPB | Upstream Bio, Inc. | 543.11M | -3.48% | 253,584 | 2.85M |
| 445 | VALN | Valneva SE | 542.07M | -0.25% | 78,340 | 205.07M |
| 446 | STTK | Shattuck Labs, Inc. | 539.65M | 5.31% | 132,734 | 1.00M |
| 447 | ZURA | Zura Bio Limited | 537.02M | -1.05% | 298,392 | - |
| 448 | FULC | Fulcrum Therapeutics, Inc. | 536.80M | 2.03% | 207,442 | 80.00M |
| 449 | ESPR | Esperion Therapeutics, Inc. | 534.17M | 1.46% | 13,080,112 | 403.14M |
| 450 | IMMX | Immix Biopharma, Inc. | 524.82M | 0.51% | 327,607 | - |
| 451 | AGMB | AgomAb Therapeutics NV | 521.73M | 2.24% | 115,647 | - |
| 452 | NPCE | NeuroPace, Inc. | 519.48M | 0.52% | 79,371 | 99.99M |
| 453 | ADCT | ADC Therapeutics SA | 513.26M | 4.66% | 1,607,760 | 81.36M |
| 454 | OFIX | Orthofix Medical Inc. | 513.05M | 0.47% | 119,402 | 822.31M |
| 455 | AQST | Aquestive Therapeutics, Inc. | 511.98M | 1.08% | 445,891 | 44.55M |
| 456 | ANL | Adlai Nortye Ltd. | 504.80M | -12.76% | 973,880 | 5.40M |
| 457 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 458 | LRMR | Larimar Therapeutics, Inc. | 502.79M | -0.62% | 624,584 | - |
| 459 | ENGN | enGene Therapeutics Inc. | 502.42M | -1.32% | 108,100 | - |
| 460 | TRDA | Entrada Therapeutics, Inc. | 502.20M | -0.57% | 33,282 | 25.42M |
| 461 | STRO | Sutro Biopharma, Inc. | 499.42M | 4.74% | 236,230 | 102.48M |
| 462 | MYGN | Myriad Genetics, Inc. | 497.46M | 8.35% | 747,856 | 824.50M |
| 463 | ALLO | Allogene Therapeutics, Inc. | 497.31M | -10.53% | 55,545,964 | 22.00K |
| 464 | VREX | Varex Imaging Corporation | 494.65M | 0.51% | 59,817 | 854.40M |
| 465 | FDMT | 4D Molecular Therapeutics, Inc. | 492.14M | -0.21% | 365,709 | 85.21M |
| 466 | LXEO | Lexeo Therapeutics, Inc. | 490.46M | -0.75% | 253,915 | - |
| 467 | KMDA | Kamada Ltd. | 489.31M | -0.71% | 16,625 | 180.46M |
| 468 | CTNM | Contineum Therapeutics, Inc. | 488.36M | 0.85% | 261,654 | - |
| 469 | RGNX | REGENXBIO Inc. | 480.56M | 0.11% | 286,016 | 170.44M |
| 470 | PACB | Pacific Biosciences of California, Inc. | 480.18M | 1.27% | 2,980,257 | 160.01M |
| 471 | ABSI | Absci Corporation | 479.72M | -0.48% | 1,692,529 | 2.80M |
| 472 | CATX | Perspective Therapeutics, Inc. | 479.66M | -0.94% | 443,357 | 884.00K |
| 473 | IVVD | Invivyd, Inc. | 475.11M | 4.35% | 612,856 | 53.43M |
| 474 | BNTC | Benitec Biopharma Inc. | 474.43M | 4.53% | 91,146 | - |
| 475 | XOMA | XOMA Royalty Corporation | 472.22M | 0.56% | 54,026 | 52.15M |
| 476 | ASMB | Assembly Biosciences, Inc. | 471.28M | 0.92% | 22,953 | 72.30M |
| 477 | IPSC | Century Therapeutics, Inc. | 469.97M | 10.34% | 687,689 | 109.16M |
| 478 | FLGT | Fulgent Genetics, Inc. | 469.88M | 1.69% | 236,657 | 322.67M |
| 479 | VTVT | vTv Therapeutics Inc. | 464.49M | -2.35% | 23,368 | 17.00K |
| 480 | ARMP | Armata Pharmaceuticals, Inc. | 460.84M | -2.33% | 12,821 | 4.90M |
| 481 | AVIR | Atea Pharmaceuticals, Inc. | 460.50M | -0.34% | 88,726 | - |
| 482 | KIDS | OrthoPediatrics Corp. | 454.77M | 0.73% | 148,691 | 236.35M |
| 483 | DNA | Ginkgo Bioworks Holdings, Inc. | 453.43M | 0.91% | 491,577 | 170.16M |
| 484 | AURA | Aura Biosciences, Inc. | 453.22M | -0.35% | 200,438 | - |
| 485 | EBS | Emergent BioSolutions Inc. | 450.08M | 0.64% | 194,307 | 742.90M |
| 486 | EPRX | Eupraxia Pharmaceuticals Inc. | 447.41M | 2.29% | 33,939 | - |
| 487 | ALT | Altimmune, Inc. | 437.15M | 2.13% | 1,049,848 | 41.00K |
| 488 | ANGO | AngioDynamics, Inc. | 434.74M | -0.38% | 160,017 | 313.73M |
| 489 | PRTC | PureTech Health plc | 434.01M | 0.17% | 2,996 | 6.39M |
| 490 | VNDA | Vanda Pharmaceuticals Inc. | 429.12M | -0.82% | 481,088 | 216.11M |
| 491 | ENTA | Enanta Pharmaceuticals, Inc. | 423.10M | -0.34% | 31,240 | 66.98M |
| 492 | AGL | agilon health, inc. | 421.26M | 11.93% | 198,517 | 5.93B |
| 493 | PRLD | Prelude Therapeutics Incorporated | 420.93M | 15.91% | 397,983 | 12.14M |
| 494 | CYH | Community Health Systems, Inc. | 416.32M | 1.30% | 505,277 | 12.49B |
| 495 | RCKT | Rocket Pharmaceuticals, Inc. | 414.67M | 4.40% | 1,374,854 | - |
| 496 | AKBA | Akebia Therapeutics, Inc. | 412.53M | -1.28% | 1,131,545 | 236.20M |
| 497 | CGC | Canopy Growth Corporation | 412.36M | 5.05% | 7,346,652 | 203.04M |
| 498 | LCTX | Lineage Cell Therapeutics, Inc. | 408.50M | 3.14% | 1,180,410 | 14.56M |
| 499 | WEAV | Weave Communications, Inc. | 408.19M | 3.39% | 519,252 | 239.02M |
| 500 | NRC | National Research Corporation | 401.93M | 3.70% | 30,132 | 137.39M |